Stockreport

IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial

AstraZeneca PLC - American Depositary Shares  (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF Longest survival follow-up ever reported for immunotherapy treatment in this setting WILMINGTON, Del.--(BUSINESS WIRE)--Updated exploratory results from the TOPAZ-1 P [Read more]